ANXA7 and prostate carcinoma: Our current findings suggest that the wt-ANXA7 was able to inhibit the proliferation of prostate cancer cells; enhance the sensitized prostate cancer cells, leading to cell death; and identify signaling pathways that were responsible for the tumor suppressor function.